MoonLake Immunotherapeutics reports on week 16 results of the VELA Phase 3 hidradenitis suppurativa program with the Nanobody® sonelokimab

VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe ...

MoonLake Immunotherapeutics AG: MoonLake Immunotherapeutics reports on week 16 results of the VELA Phase 3 hidradenitis suppurativa program with the Nanobody sonelokimab

VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe hidradenitis suppurativa (HS) and the first Phase 3 ...

The Japanese Walking Method Might Change How You Use Walking for Fitness

The Japanese walking method is gaining attention as a low-impact workout with huge benefits. Learn how the interval walking ...

Velocity-Based Training vs. Compensatory Acceleration: Why Intent Beats Numbers

I know this stuff can get a little high-level and “strength-and-conditioning-nerdy,” but stick with me. My goal here is to help OnSI athletes and the everyday a ...
Open Heart

Outpatient heart failure specialist care following acute heart failure hospitalisation improves long-term outcomes

Background Hospitalisation with acute heart failure (AHF) carries a high risk of death, and those surviving to discharge ...